M. Thomas Stillman, MD, FACP

General Internal Medicine


Commitment to Patient-Centered Care

"I have always stressed the importance of the doctor-patient relationship with emphasis on the bedside examination."

Clinical Expertise

Dr. Stillman's major research interests have been arthritis therapy and the use of non-steroidal anti-inflammatory drugs (NSAIDs), renal and gastric toxicity. He has lectured extensively, nationally and internationally on these subjects. He served 7 years on the FDA Arthritis Advisory Committee with particular interest in NSAID related renal issues.

Credibility

  • Director of the Division of Rheumatology, HCMC for 30 years
  • Director of Undergraduate Medical Education for 17 years
  • Professor of Medicine, University of Minnesota School of Medicine

Honors

  • AOA Faculty Teaching Award 2016
  • Selected by U of MN students to be "greeter" for past 16 commencement ceremonies
  • Minnesota Medical Foundation Distinguished Teaching Award/Clinical Faculty, 1996-2000, 2004
  • Minnesota Medical Foundation Outstanding Medical School Teacher Award, 1998
  • Lifetime Teaching Award from the Minnesota Medical Foundation, 2005
  • Harold S. Diehl Award, 2005
  • Leonard Tow Humanism in Medicine Award, 2008
  • University of Minnesota Cardiology Fellows' Faculty Teaching Award, 2009

Professional Affiliations

  • Alpha Omega Alpha Honor Medical Society
  • Phi Beta Kappa
  • Hennepin County Medical Society
  • Minneapolis Society of Internal Medicine
  • Fellow, American College of Physicians
  • American Rheumatism Association
  • Founding Fellow, American College of Rheumatology
  • CDIM Clerkship Directors in Internal Medicine
  • Minnesota Arthritis Foundation
  • Minnesota Medical Directors Association
  • Gold Humanism Honor Society

Publications

  • Stillman MJ, Stillman MT. Appropriate use of NSAIDs; Considering cadiovascular risk in the elderly. Geriatrics. 2007;62(3):16-21.
  • Stillman MJ, Stillman MT. Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly; a clinical use pathway. Geriatrics. 2007;62(2):26-34.
  • Stillman MT, Schlesinger PA. NSAID nephrotoxicity: should we be concerned? Arch Intern Med. 1990;150:268-270.
  • Blackshear JL, Napier JS, Davidman M, Stillman MT. Renal complications of non-steroidal anti-inflammatory drugs: identification and monitoring of those at risk. Semin Arthritis Rheum.1985;14:163-175.
  • Stillman MT, Napier JS. Adverse effects of non-steroidal anti-inflammatory drugs on the kidney. Med Clin North Am.1984;68:371-385.

 

Medical School

University of Minnesota, Minneapolis, MN, USA

Residency

Internal Medicine, Hennepin County Medical Center, Minneapolis, MN, USA

Fellowship

Clinical Rheumatology, Mayo Clinic, Rochester, MN, USA

Rheumatology, Madigan General Hospital, Tacoma, WA, USA

Rheumatology, Madigan General Hospital, Tacoma, WA, USA